Key Insights

Highlights

Success Rate

77% trial completion

Published Results

19 trials with published results (11%)

Research Maturity

57 completed trials (33% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.9%

17 terminated out of 172 trials

Success Rate

77.0%

-9.5% vs benchmark

Late-Stage Pipeline

5%

8 trials in Phase 3/4

Results Transparency

33%

19 of 57 completed with results

Key Signals

19 with results77% success17 terminated

Data Visualizations

Phase Distribution

139Total
Not Applicable (88)
Early P 1 (4)
P 1 (7)
P 2 (32)
P 3 (5)
P 4 (3)

Trial Status

Completed57
Recruiting38
Unknown27
Terminated17
Active Not Recruiting13
Not Yet Recruiting11

Trial Success Rate

77.0%

Benchmark: 86.5%

Based on 57 completed trials

Clinical Trials (172)

Showing 20 of 20 trials
NCT06945380Not ApplicableRecruitingPrimary

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

NCT04415892Not ApplicableRecruitingPrimary

The Role of TRP Channels in CIPN

NCT07455409Not ApplicableCompletedPrimary

Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy

NCT07558447Not ApplicableRecruitingPrimary

Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy

NCT07556965Not ApplicableNot Yet Recruiting

Exercise and Mindfulness Intervention for Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

NCT06389721RecruitingPrimary

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

NCT05348408Phase 2CompletedPrimary

Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy

NCT04888988Not ApplicableActive Not RecruitingPrimary

Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

NCT07064798Not ApplicableRecruitingPrimary

Cryocompression for CIPN

NCT07219472Not ApplicableRecruitingPrimary

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

NCT07016971Phase 1Not Yet RecruitingPrimary

CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

NCT05840562Phase 3RecruitingPrimary

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

NCT07072468Phase 2RecruitingPrimary

Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

NCT06405542Phase 1Active Not RecruitingPrimary

Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN)

NCT04763356Not ApplicableRecruitingPrimary

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

NCT07365007Not ApplicableRecruitingPrimary

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

NCT05771974Not ApplicableActive Not RecruitingPrimary

The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy

NCT06769061Not ApplicableRecruiting

The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients

NCT05528263Not ApplicableCompleted

Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)

NCT06162403Not ApplicableRecruiting

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Scroll to load more

Research Network

Activity Timeline